Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA

Showing 15 posts of 1442 posts found.

Blog footer

Digital Pharma: Online trial safety reporting

June 21, 2010
Research and Development FDA, MHRA, digital research, drug safety

From September all serious adverse events that occur during clinical trials in the UK will have to be reported electronically …

News
NHS Football Fitness

Digital Pharma: Byte-sized roundup

June 18, 2010
Medical Communications, Research and Development FDA, Genzyme, NHS, Pfizer, digital pharma med coms, digital pharma research, social media

This week’s roundup includes an NHS football fitness game, Pfizer’s virtual exhibition booth, Amgen’s oncology site, reports FDA social media …

News

FDA to make safety reviews public

June 16, 2010
Research and Development, Sales and Marketing FDA, drug safety

The US medicines regulator is to make safety reviews of recently approved prescription medicines more readily available to the public. …

News
Digital Pharma Guide footer

Pharma’s Digital Revolution – The Story So Far

May 12, 2010
Medical Communications Digital Pharma Guide, FDA, Twitter, blog, community, digital pharma, ipad, social networking

The internet and digital communication are transforming all aspects of pharma’s work. From social media to drug discovery, here are …

Feature
Blog footer

Digital Pharma: AZ outlines its online principles

March 2, 2010
Medical Communications FDA, digital pharma, social media

AstraZeneca says it has an obligation to use social media to help empower patients and prescribers to make informed decisions …

Feature

Clinical research news in brief

March 2, 2010
Research and Development Community Research, Evotec, FDA, INC Research, Kendle, Parexel

A round-up of recent developments in the clinical research arena includes proposals from the FDA on reporting falsified trials, Kendle’s …

News

Single orphan document will simplify process for industry

March 1, 2010
Research and Development EMA, FDA, Orphan

The FDA and European Medicines Agency are to simplify the regulatory process for orphan medicines by agreeing to accept a …

News

Rituxan gains approval for most common leukaemia

February 19, 2010
Sales and Marketing FDA, MabThera, Rituxan, blood cancer

Roche’s blockbuster cancer treatment MabThera/Rituxan has been approved by the FDA for the treatment of adult leukaemia. The drug earned …

News

FDA to study effects of medication during pregnancy

January 20, 2010
Research and Development, Sales and Marketing FDA, paediatric

A new US-based collaborative research programme to study the effects of medication on mothers and their babies has been launched. …

News

FDA begins consumer transparency initiative

January 13, 2010
Research and Development, Sales and Marketing FDA, transparency

The Food and Drug Administration has unveiled the first phase of its transparency initiative, designed to make its drug approval …

News
FDA’s Deputy Commissioner for International Programs Murray Lumpkin

Transatlantic conversations

January 11, 2010
Research and Development EMA, FDA

The Pharmafocus interview: Murray Lumpkin, FDA Deputy Commissioner for International ProgramsCollaborations between the world’s leading medicines regulators have increased markedly …

Feature
FDA's Twitter account

Digital Pharma: FDA listens on social media

November 16, 2009
Medical Communications FDA, digi, digital pharma, social media

The FDA’s last internet-related hearing took place more than ten years ago in 1996, a time when its concerns centred around …

Feature
Solvay's Russian Twitter account

Digital Pharma: Byte-sized roundup

November 13, 2009
Medical Communications FDA, Merck Serono, Solvay, digital pharma, google, social media

Solvay Pharma has joined the ranks of pharma companies using Twitter, setting up a Russian language account for its Moscow-based …

News
FDA's social media hearing

Digital Pharma: Counting down to the FDA’s social media hearing

November 9, 2009
Medical Communications FDA, digi, social media

 Later this week the FDA will hold its hotly anticipated hearing on pharma’s use of social media.The ‘Public Hearing on …

Feature
The #fdasm website

Digital Pharma: Counting down to the FDA’s social media hearing

November 9, 2009
Medical Communications FDA, digi, digital pharma, industry, social media

Later this week the FDA will hold its hotly anticipated hearing on pharma’s use of social media.The ‘Public Hearing

Feature
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026